Latest Bisphosphonate Stories
Treatment with bisphosphonate therapy appears to be associated with an increased risk of atypical fractures of the femur.
Bone cancer-related fractures and pain can be reduced by drug treatment, but no one drug is superior.
The Food and Drug Administration (FDA) announced today that physicians should reassess patients with osteoporosis who are being treated with a class of drugs called bisphosphonates after three to five years of therapy to determine whether they should continue treatment.
On March 19th, 2012 the US FDA announced the approval of the first Boniva generics to treat or prevent osteoporosis. Boniva and Fosamax belong to the class of drugs known as bisphosphonates.
Drugs that are commonly used to prevent osteoporosis may increase the risk of serious inflammatory eye disease in first-time users.
Low bone density medications, such as Fosamax, Boniva and Actonel, may have a protective effect for endometrial cancer, according to a study at Henry Ford Hospital.
- Withering but not falling off, as a blossom that persists on a twig after flowering.